GAMCO Investors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-59,350
Closed -$2.43M 906
2024
Q2
$2.43M Sell
59,350
-9,487
-14% -$388K 0.03% 465
2024
Q1
$2.91M Buy
68,837
+6,555
+11% +$277K 0.03% 430
2023
Q4
$2.64M Buy
+62,282
New +$2.64M 0.03% 445